Provisional Agenda
(Subject to change: The conference may finish earlier or later than the advertised times each day)
Event type: Virtual/in-person hybrid
Presentation language: English
Venue: The Jarvis Doctorow Hall, St Edmund Hall, Queen’s Lane, Oxford, UK
Time Zone: All times mentioned refer to British Standard (BST) – London/GMT +01:00.
Password and links: Registered conference delegates will be sent joining information and conference access links a few days before the conference.
World Time Converter: https://greenwichmeantime.com/time-gadgets/time-zone-converter | https://greenwichmeantime.com/timepiece/world-clock | https://www.worldtimebuddy.com
NB: Due to the hybrid nature of the agenda and the wide geographical locations of our speakers, it may not always be possible to group related presentations together.
DAY 1: 01 September
0800: Registration
0900-1730: Presentations including lunch, refreshments and poster viewing
1900: Networking dinner (further information will be sent by email)
DAY 2: 02 September
0900: Accommodation checkout
0930-1530: Presentations including lunch, refreshments and poster viewing
1530: General discussion, networking and departure
Dr Deborah Hinton (Keynote speaker)
Senior Investigator & Chief, Gene Expression and Regulation Section, Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
Uncovering a metabolism thermostat in Escherichia coli and the phage T4 proteins that manipulate it
Professor Martha Clokie (Conference chair)
Professor of Microbiology, Centre for Phage Research, University of Leicester, Leicester, UK
Changing where and how we look for phages: combining hidden genomes with mass isolation to expand the therapeutic phage landscape
Professor Thomas Sicheritz-Pontén
Professor, Globe Institute, University of Copenhagen, Copenhagen, Denmark
Towards biologically explainable AI for phage host prediction
Professor Michael Brockhurst
Professor & Chair in Evolutionary Biology, Division of Evolution, Infection and Genomics, University of Manchester, Manchester, UK
Resistance mutation supply modulates the benefit of CRISPR immunity against virulent phages
Professor John Chen
Associate Professor, Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Exploiting resident prophages as a therapeutic vulnerability in pathogenic bacteria
Professor Jeremy Barr
Professor and Group Leader, School of Biological Sciences, Monash University, Rainforest Walk, Clayton Campus, Clayton, VIC, Australia
Temperate bacteriophage populations in the human gut: culturomics and experimental insights
Dr Katarzyna Gembara
Group Leader, Laboratory of Phage Molecular Biology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland
Bacteriophage transfer along the gut–urinary axis after radical cystectomy with ileal urinary diversion
Professor Ville-Petri Friman
Professor in Microbiology, Department of Microbiology, University of Helsinki, Helsinki, Finland
Bacteria–phage coevolution drives variation in bacterial wilt disease incidence via resistance–virulence trade-offs
Dr Maria Mackay
Knowledge Transfer Manager ‑
A practical “good application guide” for strong commercial grants
Dr Conor Graham
Postdoctoral Scientist, Department of Bacteriology, Animal and Plant Health Agency, UK
Targeted bacteriophage suppresses Salmonella infantis while preserving the overall microbiome in a chicken gut model
Dr John Hudson
Senior Microbiological Risk Assessor, Food Standards Agency, Foss House, Kings Pool, 1-2 Peasholme Green, York, YO1 7PR, United Kingdom
A UK multi-agency sandbox addressing regulatory impediments to phage applications
Dr Karolina Filik-Matyjaszczyk
Assistant Professor, Laboratory of Medical Microbiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland
Precision Antibacterials: Integrating Phage Specificity with Immune Activation (when Bacteriophages Meet Antibodies)
Dr Alice Collins
Postdoctoral Scientist, Department of Infectious Disease, Section of Molecular Microbiology and Centre for Bacterial Resistance Biology, Imperial College London, London, UK
A nucleic acid host factor enables optimal phage replication in Escherichia coli
Dr Bożena Szermer-Olearnik
Assistant Professor, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Lower Silesia, Poland
In Vitro Assessment of Lytic Bacteriophages: Physicochemical Characterization, Cytotoxicity and Immunomodulatory Potential
Dr Daniel Cazares
Postdoctoral Scientist, Department of Biology, University of Oxford, Life and Mind Building, South Parks Road, Oxford, Oxfordshire, OX1 3EL, UK
Phage constrain multidrug resistance plasmid spread
Miss Julia Ammann
Graduate Research Student, Research Unit Microbial Diseases Prevention, Institute of Virology, Helmholtz Centre Munich – German Research Centre for Environmental Health, Neuherberg, Germany
Targeted Discovery of Phage-Derived Antimicrobial Peptides Using Viral Tagging
Miss Sophie Lawson
Graduate Research Student, UK Health Security Agency (UKHSA), Porton Down, Manor Farm Road, Wiltshire, UK
Understanding the impact of phage characteristics on the interactions between phage and antibiotics
Miss Sharaine Rogers
Graduate Research Student, UK Health Security Agency, Countermeasures, Development, Evaluation and Preparedness, Porton Down, Salisbury, SP4 0JG, Wiltshire, UK
Developing a Phage Service: Challenges Faced and Lessons Learnt
Dr Matthew Wand
Senior Project Team Leader, UK Health Security Agency, Countermeasures, Development, Evaluation and Preparedness, Porton Down, Salisbury, Wiltshire, UK
Phage Activity Against Hypervirulent ST23 Klebsiella pneumoniae Reveals Extensive Strain Diversity and Capsule-Mediated Resistance
Dr Suzanne Humphrey
Lecturer, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
Determinants of temperate phage susceptibility in Enterococcus faecium: roles for anti-phage systems and resident prophages
Dr Giuseppina Mariano
Group Leader and MRC Fellow, School of Infection and Immunity, 120 University Place, University of Glasgow, Glasgow, UK
Fantastic Zoryas and where to find them
Miss Aparna Kaaraal Mohan
Graduate Research Student, Department of Engineering, University of Cambridge, Trumpington Street, Cambridge, CB2 1PZ, UK
Single-cell studies reveal phages can exploit the physiological heterogeneity of dormant bacteria
Ms Sara Alghamdi
Graduate Research Student, Becky Mayer Centre for Phage Research, Division of Microbiology and Infection, University of Leicester, Leicester, UK
Preclinical Evaluation of Phage Cocktail (LCPR1) Alone and Combined with Ertapenem for Treating Escherichia coli (ESBL) Urinary Tract Infections
Mr Javier Ignatio Neri
Graduate Research Student, Research Center for the Natural and Applied Sciences, University of Santo Tomas, España, Manila, Philippines
Bacteriophage Selective Pressure on Klebsiella pneumoniae Results in the Loss of the HMV Phenotype
Dr Rachael C Wilkinson
Postdoctoral Scientist, Becky Mayer Centre for Phage Research, Division of Microbiology and Infection, University of Leicester, Leicester LE1 7RH, UK
Structural and Functional Characterisation of a Phage-Derived Colanic Acid-Degrading Enzyme for Biofilm Disruption
Mr Nzubechukwu Ugokwe
Graduate Research Student, Becky Mayer Centre for Phage Research, Division of Microbiology and Infection, University of Leicester, Leicester LE1 7RH, UK
Genome engineering enforces cooperation as a survival strategy of phage T7: implications for phage therapy
